Botanical species · safety record

Dichondra repens

The EFSA Compendium of Botanicals holds 7 constituent measurements for Dichondra repens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Dichondra repens J.R.Forst. & G. Forst.

7Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Calystegine b2
  • Calystegine a1
  • Isoflavones1
  • Scopoletin1
  • Skimmine1
  • Umbelliferone1

Plant parts

  • Aerial part of plants5

Preparations

  • Solvent extraction5

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
ScopoletinAerial part of plantsSolvent extraction4.1 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
UmbelliferoneAerial part of plantsSolvent extraction24.5 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Calystegine aAerial part of plantsSolvent extraction1.5 Microgram/gramNo resolvable identifier
Calystegine bAerial part of plantsSolvent extraction0.6 Microgram/gramNo resolvable identifier
Calystegine bAerial part of plantsSolvent extraction0.6 Microgram/gramNo resolvable identifier
IsoflavonesNo resolvable identifier
SkimmineNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Sheu, Ming-Jyh., Deng, Jeng-Shyan., Huang, Ming-Hsing., Liao, Jung-Chun., Wu, Chieh-Hsi., Huang, Shyh-Shyun., Huang, Guan-Jhong. Antioxidant and anti-inflammatory properties of Dichondra repens Forst. and its reference compounds. FOOD CHEMISTRY, 2012, vol. 132, no. 2, p. 1010-1018. DOI
  2. Schimming, Thomas., Tofern, Britta., Mann, Petra., Richter, Anuschka., Jenett-Siems, Kristina., Drager, Birgit., Asano, Naoki., Gupta, Mahabir P., Correa, Mireya D., Eich, Eckart. Phytochemistry and chemotaxonomy of the Convolvulaceae. 6. Distribution and taxonomic significance of calystegines in the Convolvulaceae. Phytochemistry, 1998, p. 1989-1995.
  3. Yang, Xiao-Feng., Qiu, Pei-Hong., Ye, Xiao-Qin. Analysis of flavonoids in Dichondra repens Forst. Guangpu Shiyanshi, 2005, p. 1211-1215.
  4. Liu, Yuming., Liang, Guangyi., Xu, Bixue. Studies on the chemical constituents from Dichondra repens Forst.. Tianran Chanwu Yanjiu Yu Kaifa, 2003, p. 15-17.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue